Loading chat...
IN SB0011
Bill
Status
1/3/2019
Primary Sponsor
Mike Bohacek
Click for details
AI Summary
-
Qualified entities operating syringe exchange programs must establish and maintain a registry containing participants' full name, date of birth, and last four digits of Social Security number
-
Registered syringe exchange participants gain a legal defense against prosecution for possession of paraphernalia and possession of controlled substances (cocaine, methamphetamine, other controlled substances) if only residual drug amounts are present in the syringe
-
Registry information is confidential and accessible only by courts, law enforcement officers, and court clerks
-
Participants may opt out of the registry but must re-register in person at least once every 365 days to maintain the legal defense
-
Individuals choosing to remain on the registry must waive HIPAA protections as a condition of registration
Legislative Description
Needle exchange program participation. Requires a qualified entity to establish and maintain a syringe exchange program registry. Provides a defense to prosecution of certain offenses related to controlled substances if: (1) a person is currently registered under a syringe exchange program; (2) the person obtained the hypodermic syringe or needle under a syringe exchange program; and (3) there is no more than a residual amount of a controlled substance located in the hypodermic syringe or needle.
Last Action
Senator Merritt added as second author
1/3/2019